bosentan anhydrous has been researched along with Chronic Primary Open Angle Glaucoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Garhöfer, G; Hommer, A; Karl, K; Resch, H; Schmetterer, L; Weigert, G; Wolzt, M | 1 |
1 other study(ies) available for bosentan anhydrous and Chronic Primary Open Angle Glaucoma
| Article | Year |
|---|---|
Effect of dual endothelin receptor blockade on ocular blood flow in patients with glaucoma and healthy subjects.
Topics: Administration, Oral; Aged; Antihypertensive Agents; Blood Flow Velocity; Bosentan; Choroid; Endothelin A Receptor Antagonists; Endothelin B Receptor Antagonists; Erythrocytes; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Laser-Doppler Flowmetry; Male; Optic Disk; Regional Blood Flow; Retinal Vessels; Sulfonamides | 2009 |